PE Imaging in Pregnancy⁹⁹ᵐTc-MAA (reduced activity)

Quick Answer

Suspected pulmonary embolism in pregnancy is a common, high-stakes scenario because pregnancy is prothrombotic and the imaging choices carry both maternal (breast) and fetal radiation considerations. With a normal chest radiograph, a perfusion-only (Q-only) scan is an excellent low-dose first-line test; CTPA delivers a higher breast dose (a concern in young, radiosensitive breast tissue) while V/Q gives a marginally higher fetal dose — but both are well below fetal harm thresholds, so the decision balances the two exposures and local availability. If leg symptoms are present, bilateral lower-extremity ultrasound first can spare imaging entirely.

The two exposures to balance

In pregnancy, the imaging trade-off is breast dose vs fetal dose. CTPA gives a higher maternal breast dose (radiosensitive tissue, lifetime cancer risk in a young woman); V/Q gives a slightly higher fetal dose but a much lower breast dose. Both fetal doses are far below the ~100 mGy teratogenic/threshold range — the fetus is not the limiting concern. With a normal chest radiograph, a perfusion-only scan is preferred first-line; a normal perfusion study effectively excludes PE.

Perfusion-only strategy

A Q-only approach (skip ventilation when the CXR is normal) reduces dose and time: most pregnant patients are young with clear lungs, so ventilation adds little and a normal perfusion scan excludes PE. Many centers also reduce the MAA activity/particle number (a "half-dose" perfusion study) to further limit fetal exposure while preserving diagnostic counts. Ventilation is added only if perfusion is abnormal or the CXR is not clear.

A sensible pathway

Doses are small either way: fetal dose from both V/Q and CTPA is on the order of a fraction of a mGy to a few mGy — orders of magnitude below the ~100 mGy threshold below which radiation-related fetal harm is not expected. The maternal breast dose is where CTPA and V/Q diverge most, which is why the low-breast-dose perfusion scan is attractive in young women. Hydration and voiding reduce bladder (and thus fetal/gonadal) dose after a Tc-99m study. Shared decision-making and local expertise appropriately influence the final choice.

High-Yield Pearls

• Trade-off is breast dose (higher with CTPA) vs fetal dose (marginally higher with V/Q); both fetal doses are well below harm thresholds.
• Normal CXR → perfusion-only scan; a normal perfusion study excludes PE.
• Leg ultrasound first when DVT is suspected can avoid chest imaging altogether.

Common Pitfalls

• Withholding indicated imaging over exaggerated fetal-dose fears — the fetal dose is far below threshold, and untreated PE is far more dangerous.
• Performing full V/Q with ventilation when a normal CXR would allow a lower-dose perfusion-only study.
• Forgetting post-void hydration to reduce bladder-related fetal/gonadal dose.

Related Pages

• Base study: V/Q scan & pulmonary embolism; agent: ⁹⁹ᵐTc-MAA; related: quantitative lung perfusion.

Self-Check

Key References

• ATS/STR clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy.
• SNMMI/EANM guidance on V/Q imaging and dose-reduction (perfusion-only, reduced-activity) in pregnancy.